Seeing Is Believing
Currently out of the existing stock ratings of Casey Woodring, 12 are a HOLD (44.44%), 5 are a SELL (18.52%), 10 are a BUY (37.04%).
Analyst Casey Woodring, currently employed at JPMORGAN, carries an average stock price target met ratio of 49.05% that have a potential upside of 11.01% achieved within 44 days.
Casey Woodring’s has documented 54 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 15-Dec-2025.
Analyst best performing recommendations are on QDEL (QUIDEL).
The best stock recommendation documented was for QDEL (QUIDEL) at 4/21/2025. The price target of $25 was fulfilled within 2 days with a profit of $0.44 (1.79%) receiving and performance score of 8.96.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
Since 14-Feb-2024
$22
$-11.65 (-34.62%)
$25
2 months 3 days ago
(07-Nov-2025)
4/6 (66.67%)
$0.74 (3.48%)
34
Buy
Since 08-May-2025
$44
$10.35 (30.76%)
$43
8 months 2 days ago
(08-May-2025)
7/8 (87.5%)
$7.54 (20.68%)
196
Hold
Since 19-Sep-2024
$45
$11.35 (33.73%)
$50
10 months 28 days ago
(13-Feb-2025)
1/3 (33.33%)
$3.35 (8.04%)
42
Buy
Since 07-May-2020
$57
$23.35 (69.39%)
$50
1 years 4 months 5 days ago
(05-Sep-2024)
5/13 (38.46%)
$12.5 (28.09%)
154
Buy
Since 22-Jan-2021
$76
$42.35 (125.85%)
$100
1 years 10 months 27 days ago
(14-Feb-2024)
2/9 (22.22%)
$30.73 (67.88%)
16
Which stock is Casey Woodring is most bullish on?
Which stock is Casey Woodring is most reserved on?
What Year was the first public recommendation made by Casey Woodring?